Is AdaptHealth Corp. a good investment? AdaptHealth Corp. (AHCO) is currently trading at 10.83 USD. Market analysts have a consensus price target of 14.14 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 16.10. This valuation is generally in line with the broader market.
Earnings Schedule: AdaptHealth Corp. is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 1.17.
No, it does not currently pay a dividend.
AdaptHealth Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of -0.59.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
Community Discussion